About OBaris
OBaris is a Healthcare company based in Schlieren (Switzerland) founded in 2024 by Nevena Paunovic and David Klein Cerrejon, and was acquired by Johnson & Johnson in September 2025. A needle-free transdermal patch for self-applicable injectables is developed. Its chief executive, as recorded, is David Klein Cerrejon. Its focus areas include Life Sciences, Drug Delivery, Patches and Microneedle Patch.
Company details
OBaris was founded in 2024 in Schlieren, Switzerland, within the medtech sector. A needle-free, self-applicable transdermal patch for injectables is developed by the company, designed for administration to the inner cheek. This technology serves as a painless alternative to traditional needle injections, with operations focused on patient medication management. Convenience and comfort are addressed through the patchs design, supporting users requiring regular treatments.
- Headquarters Schlieren, Switzerland
- Founders Nevena Paunovic, David Klein Cerrejon
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website obaris.ch
- Social LinkedIn Facebook
- Acquired by Johnson & Johnson (Sep 2025)
- Investors
- Acquired byJohnson & Johnson
(Sep 2025)
Investors in OBaris
OBaris has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Johnson & Johnson.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | jnj.com | New Brunswick, United States |
Investor details for OBaris
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OBaris
2 people are tracked at OBaris (2 in leadership).
| Name | Role | Group |
|---|---|---|
Nevena Paunovic | Co-Founder | Leadership |
David Klein Cerrejon | Co-Founder & CEO | Leadership |
Complete people profiles for OBaris
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OBaris
2 dated milestones of OBaris across 1 years, from founding to its latest funding, stage changes and deals.
- Founded OBaris is founded.
- Exit Acquired by Johnson & Johnson.
Web traffic of OBaris
The website of OBaris (obaris.ch) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 5.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OBaris
OBaris was founded in 2024.
OBaris is headquartered in Schlieren, Switzerland. It is registered at Schlieren, Zurich, Switzerland.
David Klein Cerrejon is the CEO of OBaris, as recorded in our data. They have also founded this company.
OBaris was founded in 2024 in Schlieren, Switzerland, within the medtech sector. A needle-free, self-applicable transdermal patch for injectables is developed by the company, designed for administration to the inner cheek. This technology serves as a painless alternative to traditional needle injections, with operations focused on patient medication management. Convenience and comfort are addressed through the patchs design, supporting users requiring regular treatments.
OBaris has 1 investor. Key investors include Johnson & Johnson.
Yes. OBaris was acquired by Johnson & Johnson in September 2025.